Filing Flows › Steris (STE) › Q2 FY27
Steris (STE) Q2 FY27 earnings results (second quarter fiscal 2027)
10-Q filed Nov 5, 2026
Steris (STE) reported revenue of $1.6B for the second quarter fiscal 2027 (Q2 FY27), +9% from a year earlier and +6% from the quarter before. Operating margin was 18.5%, net earnings $214M (13.5% of revenue).
Steris, Q2 FY27: revenue $1.6B (+9% year over year), operating margin 18.5%, net earnings $214M, operating cash flow $289M. The chart follows the revenue to costs, profit and cash.
| Q2 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6B | +6% | +9% |
| Gross profit | $711M | +4% | +10% |
| Operating profit | $294M | +3% | +11% |
| Net earnings | $214M | +7% | +11% |
| Operating cash flow | $289M | -21% | +0.4% |
| Free cash flow | $213M | -24% | +6% |
What changed
Revenue was $1.6B in Q2 FY27, up 9% year over year and up 6% from the previous quarter. Healthcare was the largest line at 71% of revenue. Healthcare added $0.09B year over year (up 9%), 69% of the total change.
Gross margin was 44.7%, up 0.5 points from Q2 FY26. Operating profit was $0.29B, a 18.5% margin (up 0.3 points year over year). Of the extra revenue versus Q2 FY26, 22% reached operating profit, above the 18% margin then. Operating expenses grew 10% against revenue growth of 9%. The fastest-growing cost line was Other operating costs (+764%). Net earnings were $0.21B, up 11% year over year. The effective tax rate was 25.7%.
Operating cash flow was $0.29B (roughly flat year over year), 135% of net earnings. Non-cash charges added back $0.13B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.07B. Capital expenditures of $0.08B left free cash flow of $0.21B.
Questions
What was Steris' revenue in the second quarter fiscal 2027?
Steris (STE) reported revenue of $1.6B for the second quarter fiscal 2027 (Q2 FY27), +9% from a year earlier and +6% from the quarter before.
Was Steris profitable in the second quarter fiscal 2027?
Operating profit was $294M (18.5% of revenue) and net earnings $214M.
Source: Steris 10-Q on SEC EDGAR.